UBS Group
CRNC icon

UBS Group’s Cerence CRNC Stock Holding History

UBS Group’s Portfolio CRNC Stock Details CRNC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$625K Sell
79,848
-2,279
-3% -$19.9K ﹤0.01% 6044
2026
Q2 		$930K Buy
82,127
+2,733
+3% +$26.8K ﹤0.01% 5797
2026
Q1 		$501K Sell
79,394
-61,988
-44% -$558K ﹤0.01% 6085
2025
Q4 		$1.51M Sell
141,382
-45,256
-24% -$497K ﹤0.01% 5214
2025
Q3 		$2.33M Buy
186,638
+96,922
+108% +$993K ﹤0.01% 4811
2025
Q2 		$916K Sell
89,716
-333,009
-79% -$2.93M ﹤0.01% 5524
2025
Q1 		$3.34M Buy
422,725
+278,111
+192% +$3.42M ﹤0.01% 4211
2024
Q4 		$1.14M Buy
144,614
+21,653
+18% +$109K ﹤0.01% 5204
2024
Q3 		$387K Buy
122,961
+12,264
+11% +$36.1K ﹤0.01% 5412
2024
Q2 		$313K Buy
110,697
+54,646
+97% +$389K ﹤0.01% 5361
2024
Q1 		$883K Sell
56,051
-1,986
-3% -$33.6K ﹤0.01% 4698
2023
Q4 		$1.14M Buy
58,037
+19,796
+52% +$344K ﹤0.01% 4374
2023
Q3 		$779K Sell
38,241
-5,176
-12% -$130K ﹤0.01% 4302
2023
Q2 		$1.27M Buy
43,417
+24,733
+132% +$678K ﹤0.01% 4006
2023
Q1 		$525K Buy
18,684
+8,077
+76% +$207K ﹤0.01% 4645
2022
Q4 		$197K Sell
10,607
-703
-6% -$12K ﹤0.01% 5468
2022
Q3 		$179K Buy
11,310
+4,145
+58% +$93.1K ﹤0.01% 5190
2022
Q2 		$181K Sell
7,165
-7,713
-52% -$231K ﹤0.01% 5006
2022
Q1 		$537K Sell
14,878
-31,932
-68% -$1.57M ﹤0.01% 4634
2021
Q4 		$3.59M Buy
46,810
+11,506
+33% +$1.01M ﹤0.01% 3194
2021
Q3 		$3.39M Sell
35,304
-2,144
-6% -$234K ﹤0.01% 3097
2021
Q2 		$4M Buy
37,448
+9,714
+35% +$956K ﹤0.01% 2918
2021
Q1 		$2.48M Buy
27,734
+5,682
+26% +$625K ﹤0.01% 3341
2020
Q4 		$2.22M Sell
22,052
-3,576
-14% -$267K ﹤0.01% 3321
2020
Q3 		$1.25M Sell
25,628
-10,943
-30% -$525K ﹤0.01% 3477
2020
Q2 		$1.49M Buy
36,571
+28,897
+377% +$830K ﹤0.01% 3152
2020
Q1 		$118K Sell
7,674
-601
-7% -$12.6K ﹤0.01% 5139
2019
Q4 		$187K Buy
+8,275
New +$136K ﹤0.01% 5647

Other funds holding CRNC

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Paradigm Capital Management Inc
Paradigm Capital Management Inc Albany, New York $3.17B AUM 63.41% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $71.4B AUM 33.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $85.7B AUM 51.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return

UBS Group's CRNC Position: Q3 2026 in Review

UBS Group reduced its Cerence (CRNC) stake by 2.8% in Q3 2026, selling an estimated $19.9K and leaving 79,848 shares worth $625K. The position accounts for ﹤0.01% of the portfolio, ranked #6044.

UBS Group first reported a position in CRNC in Q4 2019 and has held it in 28 quarters since. The position peaked at $4M in Q2 2021. 138 funds tracked by Wall St. Rank hold CRNC as of Q3 2026.

  • UBS Group held 79,848 shares of Cerence worth $625K as of Q3 2026.
  • UBS Group sold 2,279 Cerence shares in Q3 2026, an estimated $19.9K.
  • Cerence made up ﹤0.01% of UBS Group's portfolio in Q3 2026, its #6044 holding.
  • UBS Group first reported a position in Cerence in Q4 2019 and has held it in 28 quarters since.
  • UBS Group's Cerence position peaked at $4M in Q2 2021.
  • 138 funds tracked by Wall St. Rank held Cerence as of Q3 2026.

Based on UBS Group's 13F filing for Q3 2026, filed 10 Nov 2026.